Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects.
about
Inhibitory effect of valproic acid on ovarian androgen biosynthesis in rat theca-interstitial cellsA weighted average difference method for detecting differentially expressed genes from microarray data.Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data.Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT/mTORC1 signaling pathwayPolycystic ovary syndrome in women using valproate: a review.Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signalingA pharmacogenomic method for individualized prediction of drug sensitivityA genomic approach to predict synergistic combinations for breast cancer treatmentThe Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.First evidence of genetic association between AKT2 and polycystic ovary syndromeMenstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents.Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.Modulation of gene expression in ovarian cancer by active and repressive histone marks.Molecular signatures of ovarian diseases: Insights from network medicine perspective.A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate.Computational characterization and identification of human polycystic ovary syndrome genes
P2860
Q29347087-B89EEEF7-FA7C-462E-8D8F-5AA698552EACQ31160471-1E3D9343-17C1-4C0E-8029-54FA0D571186Q33499079-8B9D75DC-725C-4071-9C25-439A2EC42AC8Q34132255-CD7EB9D6-E9C7-419E-BBAE-CCA6CBF7E58EQ34881401-3832868B-4F02-4921-8B03-973A597CB48AQ35100070-DC091B0E-0DDE-4B50-9CB9-72B1DA102F30Q35176386-708F9CAC-B086-419D-80CA-1FD912A27A71Q35670293-AF236487-9EC8-49B7-8BEE-B04278D27C39Q35676497-4280FAB0-A7DC-431A-A102-BBCCECB1E905Q36975665-A32B25E0-8C2A-4C0F-A022-C5127D8D2344Q37172865-8F8B66EE-8B93-43E6-B8FF-87D70BA8DCD8Q37830746-4FD58052-1272-4CCB-A685-DB70088A6129Q37962015-D676F0EC-5410-4E8E-9C99-533C7C7D0D99Q39657304-3751A837-1367-4EA0-B75D-6D5F1DDD03C2Q48064476-0E4F9543-80BB-4599-9902-1A3340DA9A05Q58699715-B721B1EF-8300-4225-A59B-9CEA9261B127
P2860
Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Valproate-induced alterations ...... se and metabolic side effects.
@en
Valproate-induced alterations ...... se and metabolic side effects.
@nl
type
label
Valproate-induced alterations ...... se and metabolic side effects.
@en
Valproate-induced alterations ...... se and metabolic side effects.
@nl
prefLabel
Valproate-induced alterations ...... se and metabolic side effects.
@en
Valproate-induced alterations ...... se and metabolic side effects.
@nl
P2093
P2860
P1476
Valproate-induced alterations ...... se and metabolic side effects.
@en
P2093
Erik Jansen
Jan M McAllister
Jennifer R Wood
Jerome F Strauss
Sietse Mosselman
Velen L Nelson-Degrave
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00193.2004
P577
2004-12-14T00:00:00Z